Appeals System and Its Outcomes in National Health Insurance in Taiwan

Abstract

Most appeals were again denied after expert review. Better education concerning utilization guidelines and a platform for insurer, insuree, and physician to dialog are needed to improve the effectiveness and efficiency of the appeals system.

Risk of Dementia in Adults With ADHD: A Nationwide, Population-Based Cohort Study in Taiwan

“…However, in most of the dementias, the etiology remained unclear. Even with cognitive enhancers, such as the acetylcholinesterase inhibitors, or the N-methyl D-aspartate (NMDA)-receptor antagonist, which might alleviate cognitive impairments, the cognitive decline, as well as the behavioral and psychological symptoms, are still a heavy burden for the dementia patients and their caregivers and their community (Fuh & Wang, 2008; S. J. Lin, Kuo, & Yang, 2006; Tzeng et al, 2015; Tzeng et al, 2017; H.Y.…”

Cost‐effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan

“…Donepezil, was the first drug approved by NHI for treatment of mild to moderate AD patients. According to the latest reimbursement criteria, prior authorization is required for all new patients; furthermore, patients are evaluated every 6 months after initiating treatment (Lin et al, 2006). Patients who show either a decrease in Mini-mental state examination (MMSE) of 2 or more points or an increase in Clinical Dementia Rating (CDR) of one or more points on the rating scale during follow-up evaluation, reimbursement stops.…”

<p>No Association Between Human Immunodeficiency Virus Infections And Dementia: A Nationwide Cohort Study In Taiwan</p>

“…In Taiwan, 4.97% of those older than 65 years had dementia,1 which is a heavy burden to carry for the family members of patients with dementia and their caregivers and community, and the society as a whole 2–5. Previous studies had found that the human immunodeficiency virus (HIV) infections were associated with HIV-associated neurocognitive disorders (HAND)6 and HIV-associated dementia (HAD) 7.…”